MOLLER-SAN PEDRO CLAUS JUAN (Chief Executive Officer) sold 23.3% of their position (200K shares) of Y-MABS THERAPEUTICS, INC. on the open market
Open‑market sale worth $7.31M — a significant reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 2 sales
Filed: 5/15/2020ACC: 0001104659-20-062625
DirectorOfficer· Chief Executive Officer
Since Sep 2018
-200K
Net shares
Net seller
$7.31M
Total sold
2
Open market trades
0B · 2S
2
Total transactions
200K disposed
Non-Derivative Transactions2
Common Stock
Indirect
Shares
−60.85K
Price / share
$37.75
Trade value
$2.30M
% of position
7.1%
5/13/2020
857.30K→796.46K
Common Stock
Indirect
Shares
−139.15K
Price / share
$36.02
Trade value
$5.01M
% of position
17.5%
5/14/2020
796.46K→657.30K
Total
Net shares
−200K
Net value
-$7.31M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Indirect | 5/13/2020 | S · Sale | −60.85K | $37.75 | $2.30M | 7.1% | 857.30K | 796.46K |
| Common Stock Indirect | 5/14/2020 | S · Sale | −139.15K | $36.02 | $5.01M | 17.5% | 796.46K | 657.30K |
| Total | −200K | -$7.31M | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)2
Common Stock
DirectShares owned15.63K
Common Stock
IndirectShares owned1.90K
Total
15.63K direct·1.90K indirect17.52K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 15.63K | Direct |
| Common Stock | 1.90K | Indirect |
| Total | 17.52K | 15.63K direct·1.90K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported